Combined inhibition of <scp>EZH</scp>2 and histone deacetylases as a potential epigenetic therapy for non‐small‐cell lung cancer cells
Taichi Takashina(Hokkaido University), Hirotoshi Dosaka‐Akita(Hokkaido University Hospital)
Cited by 63
Related Papers
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
|Nature Immunology|2012|832
Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant
|British Journal of Cancer|2008|33
Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials
|Frontiers in Pharmacology|2018|19
Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells
|British Journal of Cancer|2008|18